Fundz

BioCardia Appoints New Vice President of Quality

PUBLIC · BCDANov 24, 2025

Position

Vice President

Company

BioCardia

Farhan Shahab
SunnyvaleBiotechnologyHealthcareHealth CareTherapeutics

Description

On November 24, 2025, BioCardia, Inc. announced the appointment of Farhan Shahab as Vice President of Quality. This appointment reflects the company's commitment to enhance its quality management systems

Quick answer

BioCardia Appoints New Vice President of Quality (November 24, 2025). BioCardia is based in Sunnyvale, California, United States.

What did BioCardia announce on November 24, 2025?
On November 24, 2025, BioCardia, Inc. announced the appointment of Farhan Shahab as Vice President of Quality.
What does BioCardia do?
BioCardia, Inc., headquartered in Sunnyvale, California, is a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary disease.
Where is BioCardia based?
BioCardia is based in Sunnyvale, California, United States.
Which similar companies made leadership changes around the same time?
MindImmune Therapeutics (November 24, 2025), Ovid Therapeutics (December 2, 2025), QurAlis (November 10, 2025) and Enliven Therapeutics (December 11, 2025) also announced leadership changes within 45 days of BioCardia.

Source: Fundz verified event record.

Other recent leadership changes in Healthcare and Therapeutics

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at BioCardia, and when

A new leader at BioCardia brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day BioCardia raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at BioCardia, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at BioCardia. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

BioCardia

Location

320 Soquel Way

Sunnyvale, California, United States

About

BioCardia, Inc., headquartered in Sunnyvale, California, is a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary disease. CardiAMP® autologous and CardiALLO™ allogeneic cell therapies are the Company’s biotherapeutic platforms with three clinical stage product candidates in development. These therapies are enabled by its Helix™ biotherapeutic delivery and Morph® vascular navigation product platforms.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment BioCardia changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for BioCardia's next move

Learn about Strategic plan

BioCardia changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.